MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma

Multiple myeloma (MM) remains largely incurable despite significant advances in biotherapy and chemotherapy. The development of drug resistance is a major problem in MM management. Macrophage migration inhibitory factor (MIF) expression was significantly higher in purified MM cells from relapsed pat...

詳細記述

保存先:
書誌詳細
出版年:Blood
主要な著者: Wang, Qiang, Zhao, Dongyu, Xian, Miao, Wang, Zhuo, Bi, Enguang, Su, Pan, Qian, Jianfei, Ma, Xingzhe, Yang, Maojie, Liu, Lintao, Zu, Youli, Pingali, Sai Ravi, Chen, Kaifu, Cai, Zhen, Yi, Qing
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2020
主題:
Lymphoid Neoplasia
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7714094/
https://ncbi.nlm.nih.gov/pubmed/32582913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020005795
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料